Clinical usefulness of serum Mac-2 binding protein glycosylation isomer in decompensated cirrhosis

Clinical usefulness of serum Mac-2 binding protein glycosylation isomer in decompensated cirrhosis - Serum M2BPGi in decompensated cirrhosis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030234

Enrollment

500

Registered

2017-12-03

Start date

2017-12-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cirrhosis

Interventions

serum M2BPGi

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Liver cirrhosis based on laboratory results and imaging tests

Exclusion criteria

Exclusion criteria: Cases regarded by doctors as inappropriate for the enrollment for some reasons

Design outcomes

Primary

Measure	Time frame
Comparison of serum M2BPGi level between decompensated cirrhosis and compensated cirrhosis	—

Countries

Japan

Contacts

Public ContactHaruki Uojima

Kitasato University school of medicine Department of Gastroenterology

kiruha@kitasato-u.ac.jp+81-42-778-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026